Study backs government cuts to glucose test strips

A US study appears to have vindicated the Australian government’s decision to limit the number of test strips provided to type 2 diabetes patients not on insulin.

The one-year study of 450 patients found no clinical or statistical differences in HbA1c levels between groups of patients allocated to once-daily monitoring, once-daily monitoring with tailored feedback from a meter or no monitoring at all.

There was also no benefit from monitoring on health-related quality of life.

Patients were drawn from US primary care practices and were on metformin